Peyronie's disease;Induratio penis plastica

Reproduktionsmedizin

Volumn 18, Issue 6, 2002, Pages 339-344

  Leiber, C ^a   Wetterauer, U ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Erectile dysfunction; Penile curvature; Peyronie's disease

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ALPHA TOCOPHEROL; ALPHA2B INTERFERON; ANTIOXIDANT; COLCHICINE; COLLAGENASE; DACRON; ELASTASE; HLA B27 ANTIGEN; PROTEINASE INHIBITOR; SUPEROXIDE DISMUTASE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; VERAPAMIL;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EMPIRICISM; ERECTILE DYSFUNCTION; EXTRACORPOREAL LITHOTRIPSY; HISTOPATHOLOGY; HUMAN; IMPLANTATION; PATHOPHYSIOLOGY; PENIS; PEYRONIE DISEASE; PROSTHESIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; REVIEW; SEXUAL FUNCTION; TREATMENT INDICATION;

EID: 0036944580     PISSN: 14346931     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00444-002-0375-x     Document Type: Review

References (87)

1. Akkus E, Carrier S, Rehman J et al. (1994) Is colchicine effective in Peyronie's disease? A pilot study. Urology 44: 291-295
2. Akkus E, Carrier S, Baba K et al. (1997) Structural abnormalities in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. Br J Urol 79: 47-53
3. Akkus E, Ozkara H, Alici B, Demirkesen O, Akaydin A, Hattat H, Solok V (2001) Incision and venous patch graft in the surgical treatment of penile curvature in Peyronie's disease. Eur Urol 40: 531-537
4. Apaydin E, Semerci B, Kefi A et al. (1998) The use of Tamoxifen in the treatment of Peyronie's disease. Int J Impotence Res 10: [Suppl]3: 57
5. Bichler KH, Lahme S, Feil G et al. (1999) Investigations on the metabolism of collagen tissue in patients suffering from peyronie's disease. J Urol 161 [Suppl]: 204
6. Brock G, Hsu GL, Nunes L,von Heyden B, Lue TF (1997) The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol 157: 276-281
7. Butz M, Teichert HM (1998) Treatment of Peyronie's disease (PD) by extracorporal shockwaves (E5W). J Urol 159 [Suppl]: 118
8. Carson CC, Coughlin PWF (1985) Radiation therapy for Peyronie's disease: is there a place? J Urol 134: 684-686
9. Carson C, Lyles K, Newton B et al. (1996) Peyronie's disease as associated with Paget's disease of bone. Int J Impotence Res 8: No. 3: 141
10. Dalkin BL, Carter MF (1991) Venogenic impotence following dermal graft repair for Peyronie's disease. J Urol 146: 849-851
11. Davis JR, CJ (1997) The microscopic pathology of Peyronie's disease. J Urol 157: 282-284
12. De la Peyronie F (1743) Sur quelques obstacles qui s'opposent à l'ejacualtion naturelle de la semence. Mem Acad R Chir 1: 425
13. Desanctis PN, Furey CA Jr (1967) Steroid injection therapy for Peyronie's disease: a 10-year summary and review of 38 cases. J Urol 97:114-116
14. Devine CJ Jr (1997) Peyronie's disease - Introduction. International Conference on Peyronie's disease. J Urol 157: 272-275
15. Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM (1997) Proposal: trauma as the cause of the Peyronie's lesion. J Urol 157: 285-290
16. Egydio PH, Lucon AM, Arap S (2002) Treatment of Peyronie's disease by incomplete circumferential incision of the tunica albuginea and plaque with bovine pericardium graft. Urology 59: 570-574
17. Ehrlich HP (1997) Scar contracture: cellular and connective tissue aspects in Peyronie's disease. J Urol 157: 316-319
18. El-Sakka AJ, Hassoba HM, Pillarisetty RJ et al. (1997) Peyronie's disease is associated with an increase in transforming growth factor-β protein expression. J Urol 158: 1391-1394
19. El-Sakka AJ, Lue TF (1998) Peyronie's disease. Curr Opin Urol 8: 203-209
20. El-Sakka AJ, Rashwan HM, Lue TF (1998) Venous patch graft for Peyronie's disease. Part II: Outcome analysis. J Urol 160:2050-2053
21. El-Sakka AJ, Selph CA, Yen TSB et al. (1998) The effect of surgical trauma on rat tunica albuginea. J Urol 159: 1700-1707
22. Faerber GJ, Konnak JW (1993) Results of combined Nesbit penile plication with plaque incision and placement of dacron patch in patients with severe Peyronie's disease. J Urol 149:1319-1320
23. Gelbhard MK, Lindner A, Kaufman JJ (1985) The use of collagenase in the treatment of Peyronie's disease. J Urol 134: 280-283
24. Gelbhard MK, Dorey F, James K (1990) The natural history of Peyronie's disease. J Urol 144: 1376-1379
25. Gelbhard MK et al. (1994) Collagenase versus placebo in the treatment of Peyronie's disease. A critical blinded study. J Urol 148: 56-58
26. Gholami SS, Lue TF (2001) Peyronie's disease. Urol Clin North Am 28 (2): 377-390
27. Gholami SS, Lue TF (2002) Correction of penile curvature using the 16-dot plication technique: a review of 132 patients. J Urol 167: 2066-2069
28. Gianneo E, Nespoli R, Conti G, Comeri G (1999) La Peyronie's disease (IPP) and extracorporal shock waves therapy (ESWT): Our experience. J Urol: 161 [Suppl]: 20S
29. Hall SJ, Basile G, Bertero EB et al. (1995) Extensive corporeal fibrosis after penile irradiation. J Urol 153: 372-377
30. Hatzichristou DG, Hatzimouratidis K, Apostloidis A, Tzortzis V, Beros A, Ioannidis E (2002) Corporoplasty using tunica albuginea free grafts for penile curvature: Surgical technique and long-term results. J Urol 167: 1367-1370
31. Hauck EW, Altinkilic BM, Ludwig M et al. (2000) Extracorporal Shock Wave Therapy in the Treatment of Peyronie's disease. Eur Urol 38:663-670
32. Hauck EW, Bschleipfer T, Diemer T, Manning M, Schroeder-Printzen I, Weidner W (2002) Long-term results of plaque thinning with carbide burs, small incisions and venous grafting for correcting complex penile curvature in Peyronie's disease: Poor results of an "ideal" approach. J Urol 167: 2070-2073
33. Hellstrom WJ, Bivalacqua TJ (2000) Peyronie's disease: etiology, medical and surgical therapy. J Androl 21: 347-354
34. Helweg G, Judmaier W, Buckberger W et al. (1992) Peyronie's disease: MR findings in 28 patients. AJR 158: 1261-1264
35. Hinman F (1980) Etiologic factors in Peyronie's disease. Urol Int 35: 407-413
36. Jarrow JP, Lowe FC (1997) Penile trauma: An etiologic factor in Peyronie's disease and erectile dysfunction. J Urol 158: 1388-1390
37. Jordan GH, Angermeier KW (1993) Preoperative evaluation of erectile function with dynamic infusion cavernosometry/cavernosography in patients undergoing surgery for Peyronie's disease: correlation with postoperative results. J Urol 150: 1138-1142
38. Kadioglu A, Usta M, Kadioglu P (1996) Diabetes mellitus is more commenly associated with Peyronie's disease in Turkey. Int J Impotence Res 8: No. 3: 188
39. Kelami A (1983) Classification of congenital and acquired penile deviation. Urol Int 38: 229-233
40. Kelami A (1983) Autophotography in evaluation of functional penile disorders. Urology 21: 628-629
41. Knispel HH, Wegner HEH, Andresen R et al. (1994) Management of Peyronie's disease with local Interferon alpha 2B - A new clinical approach. Int J Impotence Res 6 [Suppl 1]: 40
42. Krishnamurti S (1995) Penile dermal flap for defect reconstruction in Peyronie's disease: operative technique and four year's experience in 17 patients. Int J Impotence Res 7: 195-208
43. Lahme S, Götz T, Bichler KH (2002) Collagen Fleece for Defect Coverage Following Plaque Excision in Patients with Peyronie's Disease. Eur Urol 41: 401-405
44. La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F et al. (2001) Peyronie's Disease: Prevalence and Association with Cigarette Smoking. Eur Urol 40: S25-S30
45. Leffell MS (1997) Is there an immunogenetic Basis for peyronie's disease? J Urol 157: 295-297
46. Levine LA, Coogan CL (1996) Penile vascular assessment using color duplex sonography in men with Peyronie's disease. J Urol 155: 1270-1273
47. Levine LA (1997) Treatment of Peyronie's disease with intralesional verapamil injection. J Urol 158: 1395-1399
48. Levine LA, Lenting EL (1997) A surgical algorithm for the treatment of Peyronie's disease. J Urol 158: 2149-2152
49. Levine LA, Goldman KE (2000) Updated experience with intralesional verapamil injection treatment for Peyronie's disease. Progam and abstracts from the American Urological Association 95th Annual Meeting;April 29 - May 4, Atlanta, Georgia. Abstr 751
50. Lindsay MB, Schain DM, Grambsch P et al. (1991) The incidence of Peyronie's disease in Rochester, Minnesota, 1950 through 1984. J Urol 146: 1007-1009
51. Lue TF, El-Sakka AJ (1998) Venous patch graft for Peyronie's disease. Part I: technique. J Urol 160: 2047-2049
52. Maga T, Montorsi F, Salonia A et al. (1999) Arterial and arterioliar cavernosal circulation in patients with Peyronie's disease. A power doppler study. J Urol 161(4) [Suppl]: 271
53. Michel MS, Braun P, Sazova O, Musial A, Köhrmann KU, Alken P (1999) Shock-wave therapy for the treatment of Peyronie's disease: First clinical investigation for the objective determination of deviation improvement by means of artificial erection. J Urol 161 [Suppl]: 262
54. Montague DK, Angermeier KW, Lakin MM et al. (1996) AMS 3-piece inflatable penile implantation in men with Peyronie's disease: comparison of CX and Ultrex cylinders. J Urol 156:1633-1635
55. Montorsi F, Salonia A, Maga T et al. (2000) Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease. J Urol 163: 1704-1708
56. Nachtsheim DA, Rearden A (1996) Peyronie's disease is associated with an HLA class II Antigen, HLA-DQ5, implying an autoimmune etiology. J Urol 156: 1330-1334
57. Nesbit RM (1965) Congenital curvature of the phallus: report of three cases with description of corrective operations. J Urol 93: 230-233
58. Nicolai M, Cipollone G, Jantorno R et al. (1998) Intralesional Verapamil injection versus placebo in Peyronie's disease J Urol 159(5) [Suppl]: 117
59. Nyberg LM, Bias WB, Hochberg MC, Walsh PC (1982) Identification of an in herited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompability B7 cross-reacting antigens. J Urol 128: 48-51
60. Porst H (1997) Congenital and acquired penile deviations and penile fractures. 37-56. In: Porst H (Hrsg) Penile Disorders. Springer, Berlin Heidelberg New York
61. Porst H (2000) Kapitel 14 Induratio penis plastica (I. P. P.) - Morbus de la Peyronie 325-346. In: Porst H (Hrsg) Manual der Impotenz. UNI-MED, Bremen
62. Pryor JP, Farell CF (1993) Controlled clinical trial of vitamin E in Peyronie's disease. Prog Reprod Biol 9:41-45
63. Pryor JP (1987) Peyronie's disease. 245-261. In: Hendry WF (Hrsg) Recent Advances in Urology and Andrology. Churchill Livingstone, Edinburgh London
64. Pryor JP (1998) Correction of penile curvature and Peyronie's disease: Why I prefer the Nesbit technique. Int J Impotence Res 10: 129-131
65. Ralph DJ, Brocks MD, Bottazo DF et al. (1992) The treatment of Peyronie's disease with Tamoxifen. Brit J Urol 70: 648-651
66. Ralph DJ, Al-Akraa M, Pryor JP (1995) The Nesbit operation for Peyronie's disease: 16-year experience. J Urol 154: 1362-1363
67. Ralph DJ, Mirakian R, Pryor JP et al. (1996) The immunological features of Peyronie's disease. J Urol 155: 159-162
68. Ralph DJ, Schwartz G, Moore W, Pryor JP, Ebringer A, Bottazzo GE (1997) The genetic and bacteriological aspects of peyronie's disease. J Urol 157: 291-294
69. Ralph DJ, Pryor JP (1999) Chapter 45 Peyronie's disease. 515-527. In: Carson C, Kirby R, Goldstein I (Hrsg) Textbook of Erectile Dysfunction. Isis Medical Media, Oxford
70. Riedl CR, Vorauer K, Pflüger H (1999) Recombinant human Superoxid-Dismutase (SOD) for the treatment of Peyronie's disease. J Urol 161(4) [Suppl]: 205
71. Rodrigues CI, Njo KH, Karim AM (1995) Results of radiotherapy and vitamin E in treatment of Peyronie's disease. Int J Radiat Oncol Biol Phys 31: 571-576
72. Smith BH (1969) Subclinical Peyronie's disease. Am J Clin Pathol 52(1): 385-390
73. Somers KD, Dawson DM (1997) Fibrin deposition in Peyronie's disease plaque. J Urol 157: 311-315
74. Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U (2001) The prevalence of Peyronie's disease: results of a large survey. Br J Urol 88: 727-730
75. Stearns V, Gelmann EP (1998) Does Tamoxifen cause cancer in humans? J Clin Oncol 16(2): 779-792
76. Stewart S, Malto M, Sandberg L, Colburn KK (1996) Increased serum levels of anti-elastin antibodies in patients with Peyronie's disease. J Urol 156:1330-1334
77. Tefekli A, Kandirali E, Erol H, Alp T, Koksal T, Kadioglu A (2001) Peyronie's disease in men under age 40: characteristics and outcome. Int J Impot Res 13(1): 18-23
78. Telöken C, Vaccaro F, da Ros CT (1996) Prelesional injection of Verapamil for Peyronie's disease. Int J Impotence Res 8(3): 178
79. Telöken C, da Ros CT, Graziottin T et al. (1998) The use of Tamoxifen in Peyronie's disease. Int J Impotence Res 10 [Suppl 3]: 63
80. Van de Water L (1997) Mechanisms by which fibrosis and fibronectin appear in healing wounds. Implications for Peyronie's disease. J Urol 157: 306-310
81. Vlachiotis J, Christodulu K, Tsidavis A (1996) Peyronie's disease: Penile hemodynamics testing with dynamic infusion cavernosometry and cavernosography. Int J Impotence Res 8(3): 176
82. Wayne JG, Hellstrom WJ, Reddy S (2000) Application of pericardial graft in the surgical management of Peyronie's disease. J Urol 163: 1445-1447
83. Wegner HEH, Andresen R, Knispel HH, Miller L (1997) Local interferon alpha 2B is not an effective treatment in early stage Peyronie's disease. Eur Urol 32: 190-193
84. Weidner W, Schroeder-Printzen I, Weiske WH et al. (1997) Sexual dysfunction in Peyronie's disease. An analysis of 222 patients without previous local plaque therapy. J Urol 157: 325-328
85. Weidner W, Schroeder-Printzen I, Rudnick J et al. (1999) Randomized prospective placebo-controlled therapy of Peyronie's disease (IPP) with Potaba (Aminobenzoate potassium). J Urol 161(4) [Suppl]: 205
86. Wilson SK, Delk JR (1994) A new treatment for Peyronie's disease: modelling the penis over an inflatable prothesis. J Urol 152: 1121-1123
87. Fitkin J, Ho GT (1999) Peyronie's disease: current management. Am Fam Phys 60: 549-552